아시아 태평양 제약 보조제 시장 – 2029년까지의 산업 동향 및 예측

아시아 태평양 제약 보조제 시장 분석 및 통찰력

제약 부형제는 약물 제형 및 개발에 중요한 역할을 합니다. 이러한 물질에는 약리학적으로 활성인 약물 또는 전구약물 이외의 물질이 포함됩니다. 제약 부형제는 약물을 표적 부위로 효율적으로 전달합니다. 이러한 분자는 약물이 동화되고 약물 효능을 향상시키는 동안 너무 일찍 방출되는 것을 방지합니다. 일부 제약 부형제는 약물 통합을 촉진하여 혈류에서 약물 흡수를 증가시킵니다.

또한, 제약 부형제는 약물 식별에도 사용됩니다. 제약 부형제는 또한 약물 맛을 향상시키는 데 사용되어 환자의 순응도, 특히 어린이의 순응도를 높입니다. 제약 부형제의 화학적 특성에 따라 유기 및 무기 공급원에서 얻을 수 있습니다. 유기 화학 물질에는 탄수화물, 석유화학 제품 , 올레오케미컬 및 단백질 등이 있습니다. 제약 부형제는 결합제, 충전제, 희석제, 현탁제 또는 코팅제, 향미제, 붕해제, 착색제, 윤활제 및 활택제, 감미료 및 방부제 등으로 작용할 수 있습니다. 제약 부형제는 결합제 및 접착제, 붕해제, 가용화제, 향미제, 유화제, 방부제, 산화 방지제, 활택제 및 킬레이트 제를 포함하여 다양한 목적으로 사용되는 여러 가지 기능을 가지고 있습니다 .

그러나 약물과 부형제 승인에 대한 규제 엄격성이 높아지고, 비용과 시간이 많이 소요되는 약물 개발 과정이 이 시장의 성장을 제약할 것으로 예상됩니다.

Data Bridge Market Research는 아시아 태평양 제약 보조제 시장이 2029년까지 1,846.41백만 달러에 도달할 것으로 예상되며, 예측 기간 동안 CAGR은 7.5%가 될 것으로 분석했습니다. 기능성은 아시아 태평양 지역에서 IT 솔루션과 서비스에 대한 수요가 빠르게 증가함에 따라 시장에서 가장 큰 유형 세그먼트를 차지합니다. 이 시장 보고서는 또한 가격 분석, 특허 분석 및 기술 발전에 대한 심층적인 내용을 다룹니다.

Asia-Pacific Pharmaceutical Excipients Market Definition

Pharmaceutical excipients involve everything in a drug except the active pharmaceutical ingredients. These molecules don’t possess medicinal properties and are ultimately used to enhance the drug's physiological absorption. Pharmaceutical excipients are inert in nature, allowing the drug molecule to apply to patients in the right form. Traditionally the pharmaceutical excipients were simple molecules, but technological innovation and increasing demand for novel drug delivery systems enhanced the pharmaceutical excipient's complexity. Pharmaceutical excipients promote the patient’s drug acceptability and boost the drug's stability and bioavailability.

Moreover, pharmaceutical excipients help maintain drug integrity, which helps in drug storage. Different pharmaceutical excipients are based on their chemical nature, including inorganic and organic chemicals. Organic chemicals include carbohydrates, petrochemicals, oleochemicals, and proteins, among others. Pharmaceutical excipients can act as binders, fillers, diluents, suspension or coating agents, flavoring agents, disintegrants, colorants, lubricants and glidants, sweeteners, and preservatives, among others.

The future of excipients science and technology has changed and continues to change. Better progress has been made in such areas as harmonizing excipient pharmacopeial monographs and applying new analytical methods to characterize excipients better.

Asia-Pacific Pharmaceutical Excipients Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

• Rise in Generic Drug Production and Uses

According to the U.S. Food and Drug Administration (U.S. Food and Drug Administration). FDA) and the National Center for Biotechnology Information (NCBI), a generic drug is a drug that has been created to look like an approved brand-name drug that is available in dosage form, with safety, strength, route of administration, quality, and performance. After the drug's patent expires, the cost savings associated with conventional drug use are not immediately apparent. Generic drugs, like brand-name drugs, require competition in the generic drug market before reducing costs; two to three years after the loss of exclusivity, the price of a generic drug is usually 60-70% lower than that of a brand-name drug. Since India has the highest per capita spending, these generic drugs will save a lot of money that can be used for other health problems. Nationally, the use of generic drugs has increased significantly in recent years. The fact that cheap substitutes for branded drugs are a major reason likely to spur the growth of the pharmaceutical industry. The generic drug industry in the near future.

Thus, increasing demand for generic drugs and rising production are expected to drive the growth of the Asia-Pacific pharmaceutical excipients market. Also, the cost of generic drugs is less, which increases the use of generic drugs.

• The Surge in Demand for Excipients

Pharmaceutical excipients are substances in pharmaceutical dosage forms not for direct therapeutic use but to facilitate the manufacture, protection, support, or improvement of stability and availability. With the increased development of the Asia-Pacific pharmaceutical industry, excipients also have a light part. Recently, there has been an increasing demand for generic drugs, which has led to an increase in the excipients demand. In addition, there has been a sharp increase in cases of chronic diseases.

Excipients are inert substances, other than pharmaceutically active drugs, introduced into the manufacturing process or included in the dosage form of pharmaceutical products. Excipients are widely used in drug formulations to add bulk to solid formulations, provide long-term stability, and facilitate drug absorption. Furthermore, it also improves the product's overall safety or functional properties during use or storage.

Thus, wide uses of excipients in drug formulation and applications of excipients are expected to drive the Asia-Pacific pharmaceutical excipients market.

Restraint

• Increasing Regulatory Stringency Regarding The Approval of Drugs and Excipients

Generic drug approval rules are largely the same worldwide, with little difference in developing countries. This is because he is not required to undergo bioequivalence (BE) study in this part of the world to obtain generic drug approval. Governments must ensure consistent quality of all generic drugs, medical experts say. Only then will doctors be happy and confident in prescribing generic drugs. A major reason for physicians' (and even patients') lack of confidence in generic drugs has been the lack of strict regulatory requirements regarding the number of generic drugs and the number of impurities allowed.

Controlling the manufacture and distribution of excipients is now considered a top priority by regulators and drug manufacturers, as mixing excipients has resulted in adverse patient events. Furthermore, with the emergence of new excipients and delivery systems, better control of the quality and supply of pharmaceutical excipients has become increasingly important in the context of in vivo activity. Recognizing the important role of excipients in pharmaceutical dosage forms requires excipient suppliers to meet the quality requirements of the pharmaceutical industry, and the pharmaceutical industry, in general, must work to ensure the product's safety. The integrity of use or storage in the supply chain. Hence, the increasing regulatory stringency regarding the approval of drugs and excipients is expected to restrain the Asia-Pacific pharmaceutical excipients market growth.

Opportunity

• Strategic Initiatives by Market Players

The rise in the pharmaceutical excipients market increases the need for strategic business ideas. It includes a partnership, business expansion, and other development. The rising demand for pharmaceuticals is significantly increasing the demand for pharmaceutical excipients, and to cope with this demand, companies are building new manufacturing sites, among other strategic initiatives.

These strategic initiatives, such as product launches, acquisitions, agreements, and business expansion by the major market player, will boost the pharmaceutical excipients market growth and is expected to act as an opportunity for the Asia-Pacific pharmaceutical excipients market.

Challenge

• Associated Side Effects

Adverse effects due to pharmaceutical excipients in drug formulations are generally uncommon, but the potential for toxicity is increased at high mg per kg doses, especially in neonates and infants. Methyl and Propyl para-hydroxybenzoate (Parabens), Benzyl Alcohol, Sodium Benzoate, Benzoic Acid, and Propylene Glycol, among others, are some of the common pharmaceutical excipients that have reported side effects.

Pharmaceutical excipients are not always the inert substances that we presume. They are intolerant to an individual or, if not properly screened, can cause chemical changes in the drug, causing the side-effect. This can affect the demand for the excipient and is expected to act as a challenge for the Asia-Pacific pharmaceutical excipients market.

Post-COVID-19 Impact on Asia-Pacific Pharmaceutical Excipients Market

The pharmaceutical industry has been severely affected by the COVID-19 pandemic. Lockdowns imposed due to the epidemic have disrupted the supply of raw materials from manufacturing centers such as India and China. This slowed drug development and production, severely affecting companies that relied heavily on outsourcing. Initially, the entire pharmaceutical ecosystem was disrupted. In addition, regulatory agencies had to draft and draft new laws to ensure maximum patient safety after using drugs. After the shutdowns ended, the pharmaceutical industry gained steam, especially due to the demand for drugs such as hydroxychloroquine and Remdesivir, which showed positive results against COVID-19. The growing demand for these drugs boosted the turnover of some companies.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology and test results involved in the pharmaceutical excipients market.

Recent Developments

• In February 2022, Kerry Group Plc., the world’s leading taste and nutrition company, announced that it had made two significant biotechnology acquisitions that have expanded its expertise, technology portfolio, and manufacturing capabilities. The company has announced that it has acquired the leading biotechnology innovation company, c-LEcta, and Mexican-based enzyme manufacturer, Enmex. c-LEcta is a leading biotechnology innovation company specializing in precision fermentation, optimized bio-processing, and bio-transformation. Also, Enmex is a well-established enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage, and animal nutrition markets. This has helped company to increase its revenue.
• In September 2022, DFE Pharma, an Asia-Pacific leader in pharma- and nutraceutical excipient solutions, opened its new “Closer to the Formulator” (C2F), a Center of Excellence, in Hyderabad, India. C2F helped pharmaceutical companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharmaceutical development. This has helped the company to showcase its progress.

Asia-Pacific Pharmaceutical Excipients Market Scope

Asia-Pacific pharmaceutical excipients market is segmented into functionality, dosage forms, route of administration, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

• BINDERS AND ADHESIVES
• DISINTEGRANTS
• COATING MATERIAL
• COLORING AGENTS
• SOLUBILIZERS
• FLAVORS
• SWEETENING AGENTS
• DILUENTS
• LUBRICANTS
• BUFFERS
• EMULSIFYING AGENTS
• PRESERVATIVES
• ANTIOXIDANTS
• SORBENTS
• SOLVENTS
• EMOLLIENTS
• GLIDENTS
• CHELATING AGENTS
• ANTIFOAMING AGENTS
• OTHERS

On the basis of functionality, the Asia-Pacific pharmaceutical excipients market is segmented into binders and adhesives, disintegrants, coating material, coloring agents, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidents, chelating agents, antifoaming agents, and others.

ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM

• SOLID
• SEMI-SOLID
• LIQUID

On the basis of dosage forms, the Asia-Pacific pharmaceutical excipients market is segmented into solid, semi-solid, and liquid

ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION

• ORAL EXCIPIENTS
•  TOPICAL EXCIPIENTS
•  PARENTERAL EXCIPIENTS
•  OTHER EXCIPIENTS

On the basis of route of administration, the Asia-Pacific pharmaceutical excipients market is segmented into oral pharmaceutical excipients, topical pharmaceutical excipients, parenteral excipients, and other excipients.

ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY END-USER

• PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
• CONTRACT FORMULATORS
• RESEARCH ORGANIZATION AND ACADEMICS
• OTHERS

On the basis of end users, the Asia-Pacific pharmaceutical excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organizations and academics, others.

ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL

• DIRECT TENDER
• RETAIL SALES
• OTHERS

On the basis of distribution channel, the Asia-Pacific pharmaceutical excipients market is segmented into direct tender, retail sales, and others.

Asia-Pacific Pharmaceutical Excipients Market Regional Analysis/Insights

The Asia-Pacific pharmaceutical excipients market is analyzed, and market size information is provided functionality, dosage forms, route of administration, end-user, and distribution channel.

The countries covered in this market report are China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of the Asia-Pacific.

In 2022, Asia-Pacific is dominating due to the presence of key market players in the largest consumer market. China is expected to grow due to the rise in technological advancement in Healthcare IT.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 국내 시장의 개별 시장 영향 요인과 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 아시아 태평양 제약 보조제 시장 점유율 분석

아시아 태평양 제약 부형제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 아시아 태평양 제약 부형제 시장에 대한 회사의 초점과만 관련이 있습니다.

아시아 태평양 제약 부형제 시장에서 활동하는 주요 기업으로는 Kerry Group plc, DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade 등이 있습니다.

연구 방법론: 아시아 태평양 제약 보조제 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 아시아 태평양 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.

SKU-69286